Published on in Vol 8, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11530, first published .
Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study

Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study

Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study

Fabienne Lecomte 1, MSc;  Anne Sophie Vignion-Dewalle 1, PhD;  Claire Vicentini 1, 2, MD;  Elise Thecua 1, MSc;  Pascal Deleporte 1, BSc;  Alain Duhamel 3, PhD;  Serge Mordon 1, PhD;  Laurent Mortier 1, 2, MD, PhD

1 U1189 - Image Assisted Laser Therapies for Oncology, Inserm, Centre Hospitalier et Universitaire de Lille, Université de Lille, Lille , FR

2 Department of Dermatology, Centre Hospitalier et Universitaire de Lille, Université de Lille, Lille , FR

3 EA 2694 - Santé Publique: Epidémiologie et Qualité des Soins, Unité de Biostatistiques, Centre Hospitalier et Universitaire de Lille, Université de Lille, Lille , FR

Corresponding Author:

  • Fabienne Lecomte, MSc
  • U1189 - Image Assisted Laser Therapies for Oncology, Inserm
  • Centre Hospitalier et Universitaire de Lille
  • Université de Lille
  • 1 avenue Oscar Lambret
  • Lille
  • FR
  • Phone: 33 3 20 44 67 22
  • Email: fabienne.lecomte@inserm.fr